Inappropriate laboratory testing in internal medicine inpatients: Prevalence, causes and interventions

por Vrijsen, B.E.L., Naaktgeboren, C.A., Vos, L.M., van Solinge, W.W., Kaasjager, H.A.H., ten Berg, M.J.
Publicado 2020

GFR estimation is complicated by a high incidence of non-steady-state serum creatinine concentrations at the emergency department

por Niemantsverdriet, M. S. A., Pieters, T. T., Hoefer, I. E., Verhaar, M. C., Joles, J. A., van Solinge, W. W., Tiel Groenestege, W. M., Haitjema, S., Rookmaaker, M. B.
Publicado 2021

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht...

por Groenhof, T. K. J., Rittersma, Z. H., Bots, M. L., Brandjes, M., Jacobs, J. J. L., Grobbee, D. E., van Solinge, W. W., Visseren, F. L. J., Haitjema, S., Asselbergs, F. W.
Publicado 2019

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis

por Berrevoets, M. C., Bos, J., Huisjes, R., Merkx, T. H., van Oirschot, B. A., van Solinge, W. W., Verweij, J. W., Lindeboom, M. Y. A., van Beers, E. J., Bartels, M., van Wijk, R., Rab, M. A. E.
Publicado 2021

The Impact of a Standardized Pre-visit Laboratory Testing Panel in the Internal Medicine Outpatient Clinic: a Controlled “On-Off” Trial

por Vrijsen, B. E. L., ten Berg, M. J., Naaktgeboren, C. A., Vis, J. Y., Dijstelbloem, H. M., Westerink, J., Dekker, D., Hoefer, I. E., Haitjema, S., Hulsbergen-Veelken, C. A. R., van Solinge, W. W., Kaasjager, H. A. H.
Publicado 2021

Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction

por van Hout, G. P. J., van Solinge, W. W., Gijsberts, C. M., Teuben, M. P. J., Leliefeld, P. H. C., Heeres, M., Nijhoff, F., de Jong, S., Bosch, L., de Jager, S. C. A., Huisman, A., Stella, P. R., Pasterkamp, G., Koenderman, L. J., Hoefer, I. E.
Publicado 2015

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE...

por van Dijk, M. J., Rab, M. A., van Oirschot, B. A., Bos, J., Derichs, C., Rijneveld, A. W., Cnossen, M. H., Nur, E., Biemond, B. J., Bartels, M., Jans, J. J., van Solinge, W. W., Schutgens, R. E., van Wijk, R., van Beers, E. J.
Publicado 2022

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE...

por van Dijk, M.J., Rab, M.A.E., van Oirschot, B.A., Bos, J.F., Derichs, C., Rijneveld, A.W., Cnossen, M.H., Nur, E., Biemond, B.J., Bartels, M., Jans, J.J.M., van Solinge, W.W., Schutgens, R.E.G., van Wijk, R., van Beers, E.J.
Publicado 2023